Cargando…

Management of intentional overdose of low-molecular-weight heparin

Detalles Bibliográficos
Autores principales:	Lu, Clara, Crowther, Mark A., Mithoowani, Siraj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CMA Impact Inc. 2022
Materias:	Practice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900780/ https://www.ncbi.nlm.nih.gov/pubmed/35101871 http://dx.doi.org/10.1503/cmaj.211083

Ejemplares similares

Prise en charge d’une surdose intentionnelle d’héparine de bas poids moléculaire
por: Lu, Clara, et al.
Publicado: (2022)

Neutropenia
por: Mithoowani, Siraj, et al.
Publicado: (2022)

Severe vitamin B(12) deficiency causing pseudo-thrombotic microangiopathy
por: McKee, Aidan, et al.
Publicado: (2023)

Measuring the anticoagulant effect of low molecular weight heparins in the critically ill
por: Crowther, Mark, et al.
Publicado: (2006)

Neutropénie
por: Mithoowani, Siraj, et al.
Publicado: (2023)

Unfractionated and low molecular weight heparin
por: Lima, Marcelo, et al.
Publicado: (2014)

A low-barrier, flexible safe supply program to prevent deaths from overdose
por: Klaire, Sukhpreet, et al.
Publicado: (2022)

Virtual overdose monitoring services: a novel adjunctive harm reduction approach for addressing the overdose crisis
por: Matskiv, George, et al.
Publicado: (2022)

Methemoglobinemia caused by sodium nitrite overdose
por: Saleh, Dana, et al.
Publicado: (2022)

Heparin-induced thrombocytopenia
por: Jevtic, Stefan D., et al.
Publicado: (2021)

Heparin/low molecular weight heparins: Thrombocytopenia: 7 case reports
Publicado: (2021)

Venlafaxine overdose treated with extracorporeal life support
por: Murphy, Laurel, et al.
Publicado: (2021)

Arterial indications for the low molecular weight heparins
por: Ageno, Walter, et al.
Publicado: (2001)

Heparin/plasma/tranexamic acid: Post-operative bleeding following intentional overdose and no response: case report
Publicado: (2022)

Effect of heparin and low-molecular weight heparin on serum potassium and sodium levels
por: Bengalorkar, Girish M., et al.
Publicado: (2011)

Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin
por: Chen, Jianle, et al.
Publicado: (2019)

The Challenge of Hemorrhagic Shock Management During Low-Molecular-Weight Heparin Treatment
por: Morotti, Alessandro, et al.
Publicado: (2020)

Low-molecular-weight heparins in the treatment of venous thromboembolism
por: Ageno , Walter, et al.
Publicado: (2000)

The Effect of Low Molecular Weight Heparins on Fracture Healing
por: Kapetanakis, Stylianos, et al.
Publicado: (2015)

Low-molecular weight heparin infusion as anticoagulation for haemodialysis
por: Wong, Steve Siu-Man, et al.
Publicado: (2016)

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
por: Perna, Alessandra F., et al.
Publicado: (2020)

A meta-analysis of bridging anticoagulation between low molecular weight heparin and heparin
por: Tao, Ende, et al.
Publicado: (2020)

Is the Incidence Trend of Heparin-Induced Thrombocytopenia Decreased by the Increased Use of Low-Molecular-Weight-Heparin?
por: Al-Eidan, Fahad A S
Publicado: (2015)

A 53-year-old woman with a suspected drug overdose
por: Kobylianskii, Jane, et al.
Publicado: (2022)

Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients
por: Volteas, Panagiotis, et al.
Publicado: (2022)

P1669: DIRECT ORAL ANTICOAGULANTS VS LOW MOLECULAR WEIGHT HEPARIN IN THE MANAGEMENT OF PATIENTS WITH PRIMARY OR METASTATIC BRAIN TUMOURS: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Yu, Wenhui, et al.
Publicado: (2023)

Low molecular weight heparin use in unexplained recurrent miscarriage
por: Yuksel, Halide, et al.
Publicado: (2014)

Low-Molecular-Weight Heparin and Unfractionated Heparin Decrease Th-1, 2, and 17 Expressions
por: Huang, Jing-Ning, et al.
Publicado: (2014)

Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease
por: Shute, Janis Kay
Publicado: (2023)

Low molecular weight heparin versus unfractionated heparin in the management of cerebral venous thrombosis: A systematic review and meta-analysis
por: Qureshi, Anjum, et al.
Publicado: (2017)

Why differentiate low molecular weight heparins for venous thromboembolism?
por: Fareed, Jawed, et al.
Publicado: (2007)

Update on the clinical use of the low-molecular-weight heparin, parnaparin
por: Camporese, Giuseppe, et al.
Publicado: (2009)

The potential benefits of low-molecular-weight heparins in cancer patients
por: Robert, Francisco
Publicado: (2010)

Diffuse alveolar hemorrhage associated with low molecular weight heparin
por: Hayashi, Shinichi, et al.
Publicado: (2013)

Use of low-molecular-weight heparin in COVID-19 patients
por: Kow, Chia Siang, et al.
Publicado: (2020)

Low molecular weight heparin in COVID-19: benefits and concerns
por: Makarem, Adham, et al.
Publicado: (2023)

Rates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar
por: Locke, Charles FS, et al.
Publicado: (2005)

The Overdose Response Strategy: Reducing Drug Overdose Deaths Through Strategic Partnership Between Public Health and Public Safety
por: Wolff, Jessica, et al.
Publicado: (2022)

Treating acetaminophen overdose
por: Sivilotti, Marco L.A., et al.
Publicado: (2022)

Monitoring of treatment with low molecular weight heparins using viscoelastic devices
por: Schött, U, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_f08m4ig1a2ba32mdjds5umv7os